153 related articles for article (PubMed ID: 18511598)
1. Hypermethylation of CXCR4 promoter in CD34+ cells from patients with primary myelofibrosis.
Bogani C; Ponziani V; Guglielmelli P; Desterke C; Rosti V; Bosi A; Le Bousse-Kerdilès MC; Barosi G; Vannucchi AM;
Stem Cells; 2008 Aug; 26(8):1920-30. PubMed ID: 18511598
[TBL] [Abstract][Full Text] [Related]
2. The expression of CXCR4 is down-regulated on the CD34+ cells of patients with myelofibrosis with myeloid metaplasia.
Rosti V; Massa M; Vannucchi AM; Bergamaschi G; Campanelli R; Pecci A; Viarengo G; Meli V; Marchetti M; Guglielmelli P; Bruno E; Xu M; Hoffman R; Barosi G; ;
Blood Cells Mol Dis; 2007; 38(3):280-6. PubMed ID: 17350297
[TBL] [Abstract][Full Text] [Related]
3. The effect of CXCL12 processing on CD34+ cell migration in myeloproliferative neoplasms.
Cho SY; Xu M; Roboz J; Lu M; Mascarenhas J; Hoffman R
Cancer Res; 2010 Apr; 70(8):3402-10. PubMed ID: 20388788
[TBL] [Abstract][Full Text] [Related]
4. [The role of stromal cell derived factor-1/CXCR4 biological axis in tumor metastasis of non-Hodgkin lymphoma].
Zhang C; Cui GH; Liu F; Wu QL; Chen Y
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):695-7. PubMed ID: 17553309
[TBL] [Abstract][Full Text] [Related]
5. Degradation of BM SDF-1 by MMP-9: the role in G-CSF-induced hematopoietic stem/progenitor cell mobilization.
Jin F; Zhai Q; Qiu L; Meng H; Zou D; Wang Y; Li Q; Yu Z; Han J; Li Q; Zhou B
Bone Marrow Transplant; 2008 Nov; 42(9):581-8. PubMed ID: 18679363
[TBL] [Abstract][Full Text] [Related]
6. Plasma levels of FL and SDF-1 and expression of FLT-3 and CXCR4 on CD34+ cells assessed pre and post hematopoietic stem cell mobilization in patients with hematologic malignancies and in healthy donors.
Cecyn KZ; Schimieguel DM; Kimura EY; Yamamoto M; Oliveira JS
Transfus Apher Sci; 2009 Jun; 40(3):159-67. PubMed ID: 19380254
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of triptolide on lymph node metastasis in patients with non-Hodgkin lymphoma by regulating SDF-1/CXCR4 axis in vitro.
Zhang C; Cui GH; Liu F; Wu QL; Chen Y
Acta Pharmacol Sin; 2006 Nov; 27(11):1438-46. PubMed ID: 17049119
[TBL] [Abstract][Full Text] [Related]
8. Promoter hypermethylation-mediated down-regulation of CXCL12 in human astrocytoma.
Zhou W; Jiang Z; Song X; Liu Y; Wen P; Guo Y; Xu F; Kong L; Zhang P; Han A; Yu J
J Neurosci Res; 2008 Oct; 86(13):3002-10. PubMed ID: 18512766
[TBL] [Abstract][Full Text] [Related]
9. Effects of chromatin-modifying agents on CD34+ cells from patients with idiopathic myelofibrosis.
Shi J; Zhao Y; Ishii T; Hu W; Sozer S; Zhang W; Bruno E; Lindgren V; Xu M; Hoffman R
Cancer Res; 2007 Jul; 67(13):6417-24. PubMed ID: 17616702
[TBL] [Abstract][Full Text] [Related]
10. Thalidomide treatment down-regulates SDF-1alpha and CXCR4 expression in multiple myeloma patients.
Oliveira AM; Maria DA; Metzger M; Linardi C; Giorgi RR; Moura F; Martinez GA; Bydlowski SP; Novak EM
Leuk Res; 2009 Jul; 33(7):970-3. PubMed ID: 18976811
[TBL] [Abstract][Full Text] [Related]
11. Molecular profiling of CD34+ cells in idiopathic myelofibrosis identifies a set of disease-associated genes and reveals the clinical significance of Wilms' tumor gene 1 (WT1).
Guglielmelli P; Zini R; Bogani C; Salati S; Pancrazzi A; Bianchi E; Mannelli F; Ferrari S; Le Bousse-Kerdilès MC; Bosi A; Barosi G; Migliaccio AR; Manfredini R; Vannucchi AM
Stem Cells; 2007 Jan; 25(1):165-73. PubMed ID: 16990584
[TBL] [Abstract][Full Text] [Related]
12. CD34+ cell responsiveness to stromal cell-derived factor-1alpha underlies rate of engraftment after peripheral blood stem cell transplantation.
Marquez-Curtis LA; Turner AR; Larratt LM; Letcher B; Lee SF; Janowska-Wieczorek A
Transfusion; 2009 Jan; 49(1):161-9. PubMed ID: 18954402
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of CXCR4 expression by SDF-KDEL in CD34(+) hematopoietic stem cells: An anti-human immunodeficiency virus strategy.
Zhang JC; Sun L; Nie QH; Huang CX; Jia ZS; Wang JP; Lian JQ; Li XH; Wang PZ; Zhang Y; Zhuang Y; Sun YT; Bai X
J Virol Methods; 2009 Oct; 161(1):30-7. PubMed ID: 19463855
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic up-regulation of CXCR4 and CXCL12 expression by 17 beta-estradiol and tamoxifen is associated with formation of DNA methyltransferase 3B4 splice variant in Ishikawa endometrial adenocarcinoma cells.
Kubarek Ł; Jagodzinski PP
FEBS Lett; 2007 Apr; 581(7):1441-8. PubMed ID: 17362937
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic silencing of CXCL12 increases the metastatic potential of mammary carcinoma cells.
Wendt MK; Cooper AN; Dwinell MB
Oncogene; 2008 Feb; 27(10):1461-71. PubMed ID: 17724466
[TBL] [Abstract][Full Text] [Related]
16. S1P(1) overexpression stimulates S1P-dependent chemotaxis of human CD34+ hematopoietic progenitor cells but strongly inhibits SDF-1/CXCR4-dependent migration and in vivo homing.
Ryser MF; Ugarte F; Lehmann R; Bornhäuser M; Brenner S
Mol Immunol; 2008 Nov; 46(1):166-71. PubMed ID: 18760838
[TBL] [Abstract][Full Text] [Related]
17. Identification of CXCR4 as a new nitric oxide-regulated gene in human CD34+ cells.
Zhang Y; Wittner M; Bouamar H; Jarrier P; Vainchenker W; Louache F
Stem Cells; 2007 Jan; 25(1):211-9. PubMed ID: 17023512
[TBL] [Abstract][Full Text] [Related]
18. Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model.
Kitaori T; Ito H; Schwarz EM; Tsutsumi R; Yoshitomi H; Oishi S; Nakano M; Fujii N; Nagasawa T; Nakamura T
Arthritis Rheum; 2009 Mar; 60(3):813-23. PubMed ID: 19248097
[TBL] [Abstract][Full Text] [Related]
19. Positive feedback activation of estrogen receptors by the CXCL12-CXCR4 pathway.
Sauvé K; Lepage J; Sanchez M; Heveker N; Tremblay A
Cancer Res; 2009 Jul; 69(14):5793-800. PubMed ID: 19584281
[TBL] [Abstract][Full Text] [Related]
20. Altered SDF-1/CXCR4 axis in patients with primary myelofibrosis and in the Gata1 low mouse model of the disease.
Migliaccio AR; Martelli F; Verrucci M; Migliaccio G; Vannucchi AM; Ni H; Xu M; Jiang Y; Nakamoto B; Papayannopoulou T; Hoffman R
Exp Hematol; 2008 Feb; 36(2):158-71. PubMed ID: 18206727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]